{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T04:47:52Z","timestamp":1785300472555,"version":"3.55.0"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T00:00:00Z","timestamp":1605744000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["#31900413"],"award-info":[{"award-number":["#31900413"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["#81520108007"],"award-info":[{"award-number":["#81520108007"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["#81770869"],"award-info":[{"award-number":["#81770869"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shandong Province Key Research and Development Program","award":["#2018CXGC1207"],"award-info":[{"award-number":["#2018CXGC1207"]}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["#ZR2018ZC1053"],"award-info":[{"award-number":["#ZR2018ZC1053"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To compare the efficacy and safety of citrate mixture and sodium bicarbonate on urine alkalization in gout patients under benzbromarone treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A prospective, randomized, parallel controlled trial was conducted among 200 gout patients in the dedicated gout clinic of the Affiliated Hospital of Qingdao University. The participants were randomly divided into two groups (1:1), sodium bicarbonate group (3\u2009g\/day) and citrate mixture group (7\u2009g\/day). All patients were prescribed with 25\u2009mg\/day benzbromarone at initiation and maintained at a dose of 50\u2009mg\/day. Clinical and biochemical data were collected at each follow-up time point (baseline, weeks 2, 4, 8 and 12).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 182 patients completed the 12-week urine alkalization study. The urine pH value of both groups increased significantly from the baseline to the final follow-up time point (sodium bicarbonate group, 5.50\u20136.00, P\u2009&amp;lt;\u20090.05; citrate mixture group, 5.53\u20135.93, P\u2009&amp;lt;\u20090.05). While the comparisons regarding urine pH between treatment groups showed no significant differences for each time point. The estimated glomerular filtration rate (eGFR) dropped significantly after 12 weeks\u2019 trial in the sodium bicarbonate group (P\u2009&amp;lt;\u20090.01), while it was comparable between baseline and the last follow-up (P\u2009&amp;gt;\u20090.05) in the citrate mixture group. Results of urine analysis showed that the incident rate of occult blood in the sodium bicarbonate group was higher than that in the citrate mixture group (38 vs 24%, P\u2009&amp;lt;\u20090.05), accompanied by a similar occurrence of kidney stones. After 12-week follow-up, the frequency of twice gout flare in the citrate mixture group was significantly lower than that in sodium bicarbonate group (4 vs 12%, P\u2009=\u20090.037). No treatment-emergent adverse events occurred.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The efficacy of citrate mixture on urine alkalization is comparable to sodium bicarbonate under benzbromarone treatment without significant adverse events. Citrate mixture is superior to sodium bicarbonate in lowering the incidence of urine occult blood and the frequency of gout attacks.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration<\/jats:title>\n                  <jats:p>Registered with ChiCTR (http:\/\/www.chictr.org.cn), No. ChiCTR1800018518.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa668","type":"journal-article","created":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T11:08:14Z","timestamp":1601204894000},"page":"2661-2671","source":"Crossref","is-referenced-by-count":23,"title":["The efficacy and safety of citrate mixture <i>vs<\/i> sodium bicarbonate on urine alkalization in Chinese primary gout patients with benzbromarone: a prospective, randomized controlled study"],"prefix":"10.1093","volume":"60","author":[{"given":"Xiaomei","family":"Xue","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinde","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2886-8285","authenticated-orcid":false,"given":"Jie","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, Qingdao, China"},{"name":"Institute of Metabolic Diseases, Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixia","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaotong","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"He","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aichang","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Sun","sequence":"additional","affiliation":[{"name":"Institute of Metabolic Diseases, Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Institute of Metabolic Diseases, Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0844-8726","authenticated-orcid":false,"given":"Tony R","family":"Merriman","sequence":"additional","affiliation":[{"name":"Institute of Metabolic Diseases, Qingdao University, Qingdao, China"},{"name":"Department of Biochemistry, University of Otago, Dunedin, New Zealand"},{"name":"Division of Clinical Immunology and Rheumatology, University of Alabama Birmingham, Birmingham, AL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changgui","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, Qingdao, China"},{"name":"Institute of Metabolic Diseases, Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,11,19]]},"reference":[{"key":"2021061821294403400_keaa668-B1","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/1756-185X.13443","article-title":"Characteristics of gout patients according to the laterality of nephrolithiasis: a cross-sectional study using helical computed tomography","volume":"22","author":"Shimizu","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"2021061821294403400_keaa668-B2","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.juro.2012.09.102","article-title":"Gout, stone composition and urinary stone risk: a matched case comparative study","volume":"189","author":"Marchini","year":"2013","journal-title":"J Urol"},{"key":"2021061821294403400_keaa668-B3","doi-asserted-by":"crossref","first-page":"S448","DOI":"10.21037\/tau.2019.05.01","article-title":"Method of alkalization and monitoring of urinary pH for prevention of recurrent uric acid urolithiasis: a systematic review","volume":"8","author":"Kamphuis","year":"2019","journal-title":"Transl Androl Urol"},{"key":"2021061821294403400_keaa668-B4","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/hy1101.092839","article-title":"Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism","volume":"38","author":"Mazzali","year":"2001","journal-title":"Hypertension"},{"key":"2021061821294403400_keaa668-B5","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000182373","article-title":"Urate deposits in the renal medulla. Prevalence and associations","volume":"29","author":"Linnane","year":"1981","journal-title":"Nephron"},{"key":"2021061821294403400_keaa668-B6","first-page":"132","article-title":"Uric acid elimination in the urine. Pathophysiological implications","volume":"147","author":"Marangella","year":"2005","journal-title":"Contrib Nephrol"},{"key":"2021061821294403400_keaa668-B7","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1177\/1060028018762103","article-title":"Lesinurad: a novel agent for management of chronic gout","volume":"52","author":"Haber","year":"2018","journal-title":"Ann Pharmacother"},{"key":"2021061821294403400_keaa668-B8","article-title":"Comparison of efficacy and safety of urate-lowering therapies for hyperuricemic patients with gout: a meta-analysis of randomized, controlled trials","author":"Fan","year":"2020","journal-title":"Clin Rheumatol"},{"key":"2021061821294403400_keaa668-B9","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.kint.2019.02.003","article-title":"Effect of thiazolidinedione therapy on the risk of uric acid stones","volume":"95","author":"Asplin","year":"2019","journal-title":"Kidney Int"},{"key":"2021061821294403400_keaa668-B10","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1681\/ASN.2009111130","article-title":"Luminal alkalinization attenuates proteinuria-induced oxidative damage in proximal tubular cells","volume":"22","author":"Souma","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"2021061821294403400_keaa668-B11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1053\/j.ajkd.2019.07.016","article-title":"Effects of sodium bicarbonate in CKD stages 3 and 4: a randomized, placebo-controlled, multicenter clinical trial","volume":"75","author":"Melamed","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"2021061821294403400_keaa668-B12","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.juro.2014.05.006","article-title":"Medical management of kidney stones: AUA guideline","volume":"192","author":"Pearle","year":"2014","journal-title":"J Urol"},{"key":"2021061821294403400_keaa668-B13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/end.2019.0292","article-title":"Alkalinizing agents: a review of prescription, over-the-counter, and\u00a0medical food supplements","volume":"34","author":"Stern","year":"2020","journal-title":"J Endourol"},{"key":"2021061821294403400_keaa668-B14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/07435800.2010.497178","article-title":"The alkalizer citrate reduces serum uric acid levels and improves renal function in hyperuricemic patients treated with the xanthine oxidase inhibitor allopurinol","volume":"35","author":"Saito","year":"2010","journal-title":"Endocr Res"},{"key":"2021061821294403400_keaa668-B15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/j.1552-4604.1984.tb01809.x","article-title":"Augmentation of renal\u00a0citrate excretion by oral potassium citrate administration: time course, dose frequency schedule, and dose-response relationship","volume":"24","author":"Pak","year":"1984","journal-title":"J Clin Pharmacol"},{"key":"2021061821294403400_keaa668-B16","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/ki.1986.201","article-title":"Successful management of uric acid nephrolithiasis with potassium citrate","volume":"30","author":"Pak","year":"1986","journal-title":"Kidney Int"},{"key":"2021061821294403400_keaa668-B17","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.urology.2010.02.029","article-title":"Long-term treatment of renal lithiasis with potassium citrate","volume":"76","author":"Spivacow","year":"2010","journal-title":"Urology"},{"key":"2021061821294403400_keaa668-B18","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2215\/CJN.00220110","article-title":"Long-term treatment with potassium citrate and renal stones in medullary sponge kidney","volume":"5","author":"Fabris","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021061821294403400_keaa668-B19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12894-020-00633-2","article-title":"Reduction of ureteral stent encrustation by modulating the urine pH and inhibiting the crystal film with a new oral composition: a multicenter, placebo controlled, double blind, randomized clinical trial","volume":"20","author":"Torrecilla","year":"2020","journal-title":"BMC Urol"},{"key":"2021061821294403400_keaa668-B20","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/acr.24180","article-title":"2020 American College of Rheumatology Guideline for the management of gout","volume":"72","author":"FitzGerald","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2021061821294403400_keaa668-B21","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/rheumatology\/kex156","article-title":"The British Society for Rheumatology Guideline for the management of gout","volume":"56","author":"Hui","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2021061821294403400_keaa668-B22","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/1756-185X.13266","article-title":"Management of gout and hyperuricemia: multidisciplinary consensus in Taiwan","volume":"21","author":"Yu","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"2021061821294403400_keaa668-B23","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1136\/annrheumdis-2015-208237","article-title":"2015 Gout classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"74","author":"Neogi","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2021061821294403400_keaa668-B24","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"2021061821294403400_keaa668-B25","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/hr.2015.23","article-title":"Association between the markers of metabolic acid load and higher all-cause and cardiovascular mortality in a general population with preserved renal function","volume":"38","author":"Park","year":"2015","journal-title":"Hypertension Res"},{"key":"2021061821294403400_keaa668-B26","first-page":"188","article-title":"Dissolution of radiolucent renal stones by oral alkalinization with potassium citrate\/potassium bicarbonate","volume":"81","author":"Trinchieri","year":"2009","journal-title":"Arch Ital Urol Androl"},{"key":"2021061821294403400_keaa668-B27","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1016\/j.bbadis.2018.03.009","article-title":"Benzbromarone aggravates hepatic steatosis in obese individuals","volume":"1864","author":"Sun","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2021061821294403400_keaa668-B28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/MEG.0b013e328358ace9","article-title":"Benzbromarone: a double-edged sword that cuts the liver?","volume":"25","author":"Haring","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2021061821294403400_keaa668-B29","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/acr.21772","article-title":"2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2021061821294403400_keaa668-B30","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1093\/rheumatology\/kex250","article-title":"The British Society for Rheumatology Guideline for the management of gout","volume":"56","author":"Hui","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2021061821294403400_keaa668-B31","doi-asserted-by":"crossref","first-page":"e031550","DOI":"10.1136\/bmjopen-2019-031550","article-title":"Gout and the risk of advanced chronic kidney disease in the UK health system: a national cohort study","volume":"9","author":"Stack","year":"2019","journal-title":"BMJ Open"},{"key":"2021061821294403400_keaa668-B32","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12882-019-1274-5","article-title":"Gout is associated with a higher risk of chronic renal disease in older adults: a retrospective cohort study of U.S. Medicare population","volume":"20","author":"Singh","year":"2019","journal-title":"BMC Nephrol"},{"key":"2021061821294403400_keaa668-B33","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/jch.13239","article-title":"Relation of uric acid level to rapid kidney function decline and development of kidney disease: the Jackson Heart Study","volume":"20","author":"Mwasongwe","year":"2018","journal-title":"J Clin Hypertension"},{"key":"2021061821294403400_keaa668-B34","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1475-2891-11-39","article-title":"Effect of urine pH changed by dietary intervention on uric acid clearance mechanism of pH-dependent excretion of urinary uric acid","volume":"11","author":"Kanbara","year":"2012","journal-title":"Nutr J"},{"key":"2021061821294403400_keaa668-B35","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s002400100200","article-title":"A comparison of the effects of potassium citrate and sodium bicarbonate in the alkalinization of urine in homozygous cystinuria","volume":"29","author":"Fjellstedt","year":"2001","journal-title":"Urol Res"},{"key":"2021061821294403400_keaa668-B36","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0302-2838(03)00317-8","article-title":"Prospective study on the efficacy of a selective treatment and risk factors for relapse in recurrent calcium oxalate stone patients","volume":"44","author":"Siener","year":"2003","journal-title":"Eur Urol"},{"key":"2021061821294403400_keaa668-B37","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.2215\/CJN.01520216","article-title":"Dietary protein and potassium, diet-dependent net acid load, and risk of incident kidney stones","volume":"11","author":"Ferraro","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021061821294403400_keaa668-B38","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/ki.2009.6","article-title":"Increased tissue acid mediates a progressive decline in the glomerular filtration rate of animals with reduced nephron mass","volume":"75","author":"Wesson","year":"2009","journal-title":"Kidney Int"},{"key":"2021061821294403400_keaa668-B39","first-page":"21460","article-title":"Prophylaxis on gout flares after\u00a0the\u00a0initiation of urate-lowering therapy: a retrospective research","volume":"8","author":"Feng","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"2021061821294403400_keaa668-B40","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3949\/ccjm.69.8.594","article-title":"Asymptomatic hyperuricemia: to treat or not to treat","volume":"69","author":"Dincer","year":"2002","journal-title":"Cleve Clin J Med"},{"key":"2021061821294403400_keaa668-B41","doi-asserted-by":"crossref","first-page":"0300060519898615","DOI":"10.1177\/0300060519898615","article-title":"Association of low urine pH as a metabolic feature with abdominal obesity","volume":"48","author":"Lee","year":"2020","journal-title":"J Int Med Res"},{"key":"2021061821294403400_keaa668-B42","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/ndt\/gfm716","article-title":"Circadian variation in urine pH and uric acid nephrolithiasis risk","volume":"23","author":"Boari","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"2021061821294403400_keaa668-B43","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/jat\/31.8.486","article-title":"Urine pH: the effects of time and temperature after collection","volume":"31","author":"Cook","year":"2007","journal-title":"J Anal Toxicol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/6\/2661\/38695036\/keaa668.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/6\/2661\/38695036\/keaa668.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T21:31:10Z","timestamp":1624051870000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/6\/2661\/5992311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,19]]},"references-count":43,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,11,19]]},"published-print":{"date-parts":[[2021,6,18]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa668","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,6,1]]},"published":{"date-parts":[[2020,11,19]]}}}